Back to Categories

Calcimimetic agent Medicines in UAE

16 medicines available

About Calcimimetic agent Medicines

This page lists all Calcimimetic agent medicines available in UAE pharmacies. Click on any medicine name to view detailed information including uses, dosage, side effects, and availability.

Complete List of Calcimimetic agent Medicines

Brand: ENDOLET | Strength: 30 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: ENDOLET | Strength: 60 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: GLANDY | Strength: 30 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: GLANDY | Strength: 60 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: HYPOCAL | Strength: 30 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: HYPOCAL | Strength: 60 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: Hypocal | Strength: 90 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: MIMPARA | Strength: 30 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: MIMPARA | Strength: 60 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: MIMPARA | Strength: 90 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: VISCAP | Strength: 30 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: VISCAP | Strength: 60 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: VISCAP | Strength: 90 mg | Form: Tablets
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; treatment of hypercalcemia in patients with parathyroid carcinoma; ...
Brand: PARSABIV | Strength: 10 mg | Form: Solution For Injection
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in adults with chronic kidney disease on dialysis Adult dose: | Initial dose of 5 mg administered intravenously three ...
Brand: PARSABIV | Strength: 2.5 mg | Form: Solution For Injection
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on dialysis Adult dose: | 5 mg administered intravenously three times a ...
Brand: PARSABIV | Strength: 5 mg | Form: Solution For Injection
Class: | Calcimimetic agent Use: | Treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on dialysis Adult dose: | Initial dose of 5 mg administered intravenousl...
Browse All Categories Search Medicines